Krazati

Krazati Coupons & Discount Card - Compare Prices Near You

Krazati (adagrasib) is a medication prescribed for the treatment of certain cancers, specifically advanced and metastatic non-small cell lung cancer (NSCLC) and colorectal cancer in adults with a specific KRAS G12C mutation. It is particularly used when prior treatments are no longer effective. For NSCLC, Krazati is taken alone, while for colorectal cancer, it is used in combination with Erbitux (cetuximab), an infusion administered weekly or biweekly. This drug functions as a KRAS G12C inhibitor. KRAS is a protein that signals cells to grow and divide. In some cancers, a KRAS G12C mutation causes uncontrolled cell growth. Krazati works by binding to the KRAS protein with this mutation, thereby inhibiting tumor growth. Krazati is conveniently available in oral tablet form, taken twice daily. However, it can cause some side effects such as diarrhea, nausea, and fatigue. Always consult with your healthcare provider to ensure this treatment is appropriate and safe for your condition.
Our Krazati coupons are free to use. You can print the coupon, email it to yourself, or receive the Krazati coupon via text message. To get your free discount, show the pharmacist your Krazati savings card which has the discounted coupon price. Use our filters below to edit the prescription box to match your needs. The Krazati prices will update based on your prescription needs. Above our Krazati coupons, you can change the location to see pharmacy prices in other areas. Our prescription discount card will update online with the specific pharmacy costs associated with your edits. Be sure to text, email, or print the Krazati savings card code that you need after editing the prescription box and location field. Show the discount card to your pharmacist before paying.

My prescription

Edit

200MG, Krazati (30 Tablets)

Select pharmacy

Pharmacy logo

Rite Aid

$3741.32

COUPON PRICE
Pharmacy logo

Albertsons

$3805.00

COUPON PRICE
Pharmacy logo

Walgreens

$3863.74

COUPON PRICE
Pharmacy logo

Walmart

$3915.96

COUPON PRICE

Krazati savings card

Show this card to your pharmacist
Pharmacy logo

Rite Aid

$3741.32

BIN

ID

PCN

GRP

019876

LHBE472862

CHIPPO

LHX

Powered by

This card is not insurance

Related KRAS inhibitor prescriptions

coupons from$2742.19Save 72%

More prescriptions for lung cancer

coupons from$2454.45Save 72%
coupons from$6742.75 
coupons from$5618.61 
coupons from$6301.64Save 72%
coupons from$11983.39Save 72%
coupons from$4963.9 
coupons from$11887.84Save 72%
coupons from$16643.83 

Related KRAS inhibitor prescriptions

Lumakras Save 72%coupons from $2742.19

More prescriptions for lung cancer

Alecensa Save 72%coupons from $2454.45
Exkivitycoupons from $6742.75
Gavretocoupons from $5618.61
Tabrecta Save 72%coupons from $6301.64
Xalkori Save 72%coupons from $11983.39
Zykadiacoupons from $4963.9
Gilotrif Save 72%coupons from $11887.84
Vizimprocoupons from $16643.83

Krazati dosage forms

The average cost for 30 Tablets of Krazati at 200MG is $3797.25 with a free coupon. This is 27.96% off the average retail price of $13581.03
DosageQuantityPrice fromPer unit
200MG30 Tablets$3797.25$126.58

Krazati Warnings

Krazati (adagrasib) is associated with several potential risks and it is essential to be aware of these while undergoing treatment. Below are important safety warnings and precautions to consider:

  • Digestive System Issues: Krazati (adagrasib) frequently causes digestive side effects such as nausea, vomiting, or diarrhea, especially within the initial weeks of treatment. While these are usually manageable with medication, in rare cases, severe issues like bleeding, blockages, or inflammation in the gut can occur, potentially becoming life-threatening. If you experience persistent stomach pain, severe nausea, or difficulty retaining food, contact your oncologist immediately. They may adjust your treatment or prescribe additional interventions.

  • Heart Rhythm Concerns: This medication can alter heart rhythms, leading to QT interval prolongation, which can be serious. Risk factors include personal or family history of heart rhythm abnormalities, low potassium or magnesium, and concurrent use of other QT-prolonging medications. Regular electrocardiograms (EKGs) and blood tests to monitor electrolyte levels will be necessary to ensure safe use.

  • Liver Health: Krazati (adagrasib) has the potential to cause liver damage, which might not present symptoms initially. Routine blood tests to monitor liver function will be required before starting treatment and monthly for the first three months. Elevated liver enzymes may be detected, indicating possible liver injury, but these often normalize within a few weeks.

  • Lung Damage: Although uncommon, lung damage can occur and may be severe. Symptoms typically appear about three months into treatment but can arise sooner or later. Report any new or worsening cough, shortness of breath, or fever to your oncologist promptly. Temporary discontinuation of the medication may be necessary to assess lung health.

It is crucial to maintain open communication with your healthcare provider throughout your treatment with Krazati (adagrasib) to manage these potential risks effectively.

Krazati Side Effects

When taking this medication, some individuals may experience common side effects such as diarrhea, nausea, fatigue, vomiting, and muscle or joint pain. These are generally mild but can become bothersome. It's helpful to manage these symptoms by eating small meals and adjusting activity levels. If symptoms persist or worsen, consulting with a healthcare provider is advised.

Serious side effects, although rare, require immediate medical attention. These include severe digestive issues like persistent stomach pain, black stools, or vomit resembling coffee grounds, which may indicate internal bleeding. Life-threatening heart problems may present as chest pain, shortness of breath, or an irregular heartbeat. Signs of liver damage include persistent nausea, yellowing of the skin or eyes, and dark urine. Additionally, this medication can cause severe lung issues, presenting as a new or worsening cough, shortness of breath, or fever.

Other effects to be aware of include dizziness, constipation, and swelling of hands or feet. If you notice symptoms like a rash, severe dizziness, or difficulty breathing, these may indicate an allergic reaction, which is rare but requires urgent care. Always report new or concerning symptoms to a healthcare professional to ensure your safety and well-being.

Krazati Interactions

Adagrasib can interact with various medications, potentially altering its effectiveness or the effectiveness of other drugs. Some medications, like levoketoconazole, rifamycins (including rifampin and rifapentine), St. John's wort, and certain seizure medications (such as carbamazepine and phenytoin), may speed up the elimination of adagrasib from your body, reducing its efficacy. Conversely, adagrasib can slow the clearance of other medications, which might enhance or prolong their effects. This includes drugs like avanafil, certain benzodiazepines (such as alprazolam, midazolam, and triazolam), dronedarone, finerenone, isavuconazonium, lomitapide, lurasidone, specific statins (such as lovastatin and simvastatin), and ticagrelor. Always consult your healthcare provider before taking new medications to ensure safety and effectiveness.
Krazati FAQs
Is Krazati chemotherapy or immunotherapy?

Krazati is not classified as chemotherapy or immunotherapy. It is a targeted therapy, specifically a KRAS G12C inhibitor, used in the treatment of certain types of cancer.

Krazati is used for the treatment of non-small cell lung cancer (NSCLC) in patients who have a specific mutation in the KRAS G12C gene. It is typically prescribed when the cancer has spread to other parts of the body or cannot be surgically removed, and after the patient has received at least one prior systemic therapy.

Krazati, also known as adagrasib, is a medication that has shown the ability to shrink tumors in certain patients with specific types of cancer. It is particularly used in cases where tumors have a KRAS G12C mutation. The effectiveness of Krazati in shrinking tumors can vary depending on individual patient factors and the specific characteristics of the cancer. It is important for patients to discuss treatment options and potential outcomes with their healthcare provider.

Krazati is not classified as chemotherapy. It is a targeted therapy medication used to treat certain types of cancer by specifically inhibiting the KRAS G12C mutation.

The cost of Krazati can vary depending on factors such as the pharmacy, location, insurance coverage, and any available discounts or assistance programs. It is recommended to contact a local pharmacy or healthcare provider for the most accurate and up-to-date pricing information. Additionally, patients may inquire about financial assistance programs that could help reduce the cost.

Related Drugs